Allurion Technologies Files 10-K/A Amendment

Ticker: ALURW · Form: 10-K/A · Filed: Aug 19, 2025 · CIK: 1964979

Sentiment: neutral

Topics: amendment, annual-report, medical-devices

TL;DR

Allurion filed an amended 10-K for 2024, check for updated info.

AI Summary

Allurion Technologies, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2024. The filing, submitted on August 19, 2025, provides updated information and disclosures. The company, previously known as Allurion Technologies Holdings, Inc., is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.

Why It Matters

This amendment to the annual report may contain updated financial figures, risk factors, or other material information that could affect investor understanding of the company's performance and outlook.

Risk Assessment

Risk Level: medium — Amendments to SEC filings can indicate a need for clarification or correction of previously reported information, potentially impacting investor confidence.

Key Numbers

Key Players & Entities

FAQ

What specific information was updated or corrected in this 10-K/A filing?

The filing is an amendment to the 10-K for the fiscal year ended December 31, 2024, indicating that previously reported information may have been updated or corrected, though the specific details of these changes are not provided in the header.

When was the company formerly known as Allurion Technologies Holdings, Inc.?

The company's name was changed from Allurion Technologies Holdings, Inc. on February 7, 2023.

What is Allurion Technologies, Inc.'s primary business classification?

Allurion Technologies, Inc. is classified under the Standard Industrial Classification code 3841, which pertains to Surgical & Medical Instruments & Apparatus.

What is the filing date of this amended 10-K report?

This 10-K/A filing was submitted on August 19, 2025.

Where is Allurion Technologies, Inc. incorporated and what is its business address?

Allurion Technologies, Inc. is incorporated in Delaware (DE) and its business address is 11 Huron Dr Ste 200, Natick, MA 01760.

Filing Stats: 4,391 words · 18 min read · ~15 pages · Grade level 16.6 · Accepted 2025-08-19 16:30:58

Key Financial Figures

Filing Documents

- Item 1A. Risk Factors

Part I - Item 1A. Risk Factors.

- Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

Part II - Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

- Item 8. Financial Statements and Supplementary Data

Part II - Item 8. Financial Statements and Supplementary Data

- Item 9A. Controls and Procedures

Part II - Item 9A. Controls and Procedures.

- Item 15. Exhibits and Financial Statement Schedules

Part IV - Item 15. Exhibits and Financial Statement Schedules. In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the certifications specified in Rule 13a-14 under the Exchange Act from the Company's Chief Executive Officer, dated as of the date hereof, are being filed or furnished, as applicable, with this Form 10-K/A as Exhibits 31.1, 31.2, 32.1 and 32.2, and an updated Consent of Independent Registered Public Accounting Firm is being filed as Exhibit 23.01. This Form 10-K/A also includes an updated Report of Independent Registered Public Accounting Firm and updated signature page. This Form 10-K/A sets forth the information in the Original Form 10-K in its entirety, as such information is amended and restated where necessary to reflect the restatement and related revisions. Except as provided above, this Form 10-K/A does not amend, update or change any other items or disclosures or otherwise reflect events occurring after the date of the Original Form 10-K to the date this Form 10-K/A is filed. Accordingly, this Form 10-K/A should be read in conjunction with the Company's other SEC filings. Except as otherwise provided, the disclosures in this Form 10-K/A are made as of the date of the Original Form 10-K and do not reflect any events that occurred after the date of the Original Form 10-K or modify or update any other disclosures in the Original Form 10-K affected by subsequent events. As such, forward-looking statements included in this Form 10-K/A may represent management's views as of the date of the Original Form 10-K and should not be assumed to be accurate as of any date thereafter. Restatement Background As described in the Company's Current Report on Form 8-K filed with the SEC on August 14, 2025, while preparing its unaudited condensed consolidated financial statements for the quarter ended June 30, 2025, the Company identified an error (the "Error") in the Company's historical consolidated

Business

Business 4 Item 1A.

Risk Factors

Risk Factors 29 Item 1B. Unresolved Staff Comments 79 Item 1C. Cybersecurity 79 Item 2.

Properties

Properties 79 Item 3.

Legal Proceedings

Legal Proceedings 80 Item 4. Mine Safety Disclosures 80 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 81 Item 6. [Reserved] 81 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 82 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 95 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 97 Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 97 Item 9A.

Controls and Procedures

Controls and Procedures 97 Item 9B. Other Information 99 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 99 PART III Item 10. Directors, Executive Officers and Corporate Governance 100 Item 11.

Executive Compensation

Executive Compensation 108 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 114 Item 13. Certain Relationships and Related Transactions, and Director Independence 116 Item 14. Principal Accountant Fees and Services 121 PART IV Item 15. Exhibits and Financial Statement Schedules 123 Item 16. Form 10-K Summary 127 i Cautionary Statement Regarding Forward-Looking Statements This Amended Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, which are not purely historical, include, but are not limited to, statements regarding the plans, strategies and prospects, both business and financial, of Allurion Technologies, Inc. ("Allurion", the "Company", "we", "our", or "us"). Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors. Such risks, uncertainties and other factors could cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words "believes", "estimates", "expects", "projects", "target", "goal", "forecasts", "may", "will", "potential", "should", "would", "could", "future", "seeks", "plans", "predicts", "propose", "scheduled", "anticipates", "intends", or similar expressions. Such statements are based on the beliefs and assumptions of the management of Allurion. Although Allurion believes that its plans, intentions and expectations reflected i

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing